Katherine Tai Sticks Up For China Tariffs At Aspen Security Forum
Katherine Tai sticks up for domestic economy in international trade relations during Aspen Security Forum.
Senator Tillis Says U.S. Needs CHIPS Act for Generic Drugs in Short Supply
In Senate hearing: imported generic drugs facing consistent drug shortages need a government incentive program to help labs make life-saving commodity drugs domestically.
October Trade Deficit Up 5% As EU, Mexico Goods Gap Breaks 2022 Levels
The October trade deficit rose, but the biggest takeaway from the latest data is how much the China goods gap is in decline this year.
Is American Made Medication Preferred Over Imports?
A recent study suggests that Americans prefer locally produced medications if they are unclear where the product was made or if the lab has received bad reviews from an FDA inspection.
Currency Misalignment Monitor, December 2023
The December Currency Misalignment Monitor found dollar overvaluation edging up once again, to 17.4% against the basket of 33 other currencies included in our model.
Investments in China: NC’s Patrick McHenry is Out of Step on this Issue
It should be a no-brainer to make sure that America’s investors don’t fund any of China’s military ambitions. And yet our very own Congressman, Patrick McHenry of North Carolina, is inexplicably blocking bipartisan congressional efforts to limit U.S. investments in China.
CPA Improves Leading Trade Model to Reflect Real-World Effects of Trade
Key Points The standard widely-used trade model, GTAP, has been wrong in its forecasts of every major U.S. trade agreement. CPA economists have modified the
Big Tech Companies Still Mad With USTR Decision on Global Data Storage
Big Tech is “big mad” with Biden administration pulling out of WTO digital trade initiative. Why it was a good idea to do so.
For China, Promises Made Are Almost Always Promises Broken
Why does anyone take China’s promises seriously? Following this week’s APEC conference, the U.S. is awash in headlines about the latest agreements between Biden and Xi, most of them not even in writing.
India Lab Recalls 27 Eye Drops From U.S. Pharmacies
Another Indian lab recalling eye drops following recalls in October and instances of blindness caused by other imports from India in March.
